ResearchSafe

ALD-52 (1-Acetyl-LSD)

Category: Psychedelics. Status: Schedule I (research compound).

An LSD relative (also called 1A-LSD) thought to convert into LSD in the body. Reported to be slightly gentler and more "clear" than LSD by some users.

How it works

Likely a prodrug for LSD acting on serotonin 5-HT2A receptors.

Key facts

  • Molecular weight: 349.43 g/mol
  • Half-life: ~3-5 hours
  • Bioavailability: Oral
  • Storage: Research/reference only.

Dosing overview

  • Typical dose: Varies by individual and setting
  • Frequency: Occasional
  • Duration: Acute effects last 8-12 hours
  • Route: Oral

Protocol notes

  • Taken orally on blotter, used just like LSD with a similar long duration.

Reported benefits

  • LSD-like experience
  • Reported slightly gentler
  • Lysergamide research compound
  • Long duration

Possible side effects

  • Long, intense experiences
  • Anxiety
  • Raised heart rate and blood pressure
  • Limited human data

Community reviews of ALD-52

Rated 4 out of 5 from 1 community review by ResearchSafe members.

  • chemist_daily rated it 4/5 - My ALD-52 experience with grad school stress: The biggest thing for me was how much gentler the headspace felt? Fwiw, it seemed to make my research reading way more fluid and less overwhelming. It could just be placebo, but I felt less anxious than usual? I just wish the duration was a bit shorter 😅.

Compare ALD-52

Research and educational reference only. Not medical advice.